Inventor
MOSS NEIL
CA35 patents
⚠️ This page may combine multiple inventors who share the name “MOSS NEIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
23 patentsUS6770639B2Aug 3, 2004
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA205 citations98
US6506769B2Jan 14, 2003
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA240 citations98
US6080763AJun 27, 2000
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA128 citations98
US6916814B2Jul 12, 2005
Methods of treating cytokine mediated diseases
BOEHRINGER INGELHEIM PHARMA110 citations97
US7211575B2May 1, 2007
Methods of treating cytokine mediated diseases
BOEHRINGER INGELHEIM PHARMA54 citations92
US6852717B2Feb 8, 2005
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA43 citations92
US6489328B2Dec 3, 2002
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA29 citations92
US6268365B1Jul 31, 2001
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA31 citations92
US6228881B1May 8, 2001
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA32 citations92
US6660732B2Dec 9, 2003
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA24 citations91
US6872726B2Mar 29, 2005
Fluorinated di-aryl urea compounds
BOEHRINGER INGELHEIM PHARMA17 citations90
US7279475B2Oct 9, 2007
Fluorinated di-aryl urea compounds
BOEHRINGER INGELHEIM PHARMA13 citations82
US7078419B2Jul 18, 2006
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA15 citations82
US6765009B2Jul 20, 2004
1,4-Disubstituted benzo-fused compounds
BOEHRINGER INGELHEIM PHARMA21 citations79
US6054470AApr 25, 2000
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA7 citations73
US6844435B2Jan 18, 2005
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA4 citations62
US6284768B1Sep 4, 2001
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA4 citations62
US6156784ADec 5, 2000
Compounds useful as phosphotyrosine mimics
BOEHRINGER INGELHEIM PHARMA4 citations62
US7790712B2Sep 7, 2010
Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA5 citations61
US7335657B2Feb 26, 2008
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA2 citations61
US7115644B2Oct 3, 2006
Heterocyclic compounds
BOEHRINGER INGELHEIM PHARMA1 citations47
US7470692B2Dec 30, 2008
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA0 citations41
US7550461B2Jun 23, 2009
Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
BOEHRINGER INGELHEIM PHARMA0 citations40
BIO MEGA BOEHRINGER INGELHEIM
4 patentsUS5484771AJan 16, 1996
Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus
BIO MEGA BOEHRINGER INGELHEIM44 citations92
US5476841ADec 19, 1995
Inhibitors of herpes viral ribonucleotide reductase
BIO MEGA BOEHRINGER INGELHEIM5 citations62
US5574015ANov 12, 1996
Isosteric antiherpes peptide derivatives
BIO MEGA BOEHRINGER INGELHEIM3 citations61
US5672586ASep 30, 1997
Herpes ribonucleotide reductase inhibitors
BIO MEGA BOEHRINGER INGELHEIM0 citations42
BOEHRINGER INGELHEIM CA LTD
3 patentsUS6313095B1Nov 6, 2001
Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain
BOEHRINGER INGELHEIM CA LTD19 citations84
US5830864ANov 3, 1998
Antiherpes peptide derivatives having a ureido n-terminus
BOEHRINGER INGELHEIM CA LTD4 citations61
US5846941ADec 8, 1998
Isosteric antiherpes peptide derivatives II
BOEHRINGER INGELHEIM CA LTD1 citations48